AJP - Regulatory, Integrative and Comparative Physiology, Vol 257, Issue 6 1551-R1557, Copyright © 1989 by American Physiological Society

ARTICLES

Structure-function analyses of brain angiotensin control of pressor action in rats

J. W. Wright, L. L. Jensen, K. A. Roberts, M. F. Sardinia and J. W. Harding
Department of Psychology, Washington State University, Pullman 99164-4830.

The present investigation examined the relative pressor potencies of intracerebroventricularly infused angiotensin (ANG) II, successively shortened COOH-terminal fragments through ANG II(5-8), and the analogues [Sar1]ANG II through [Sar1]ANG II(5-8). The results indicate that ANG II, ANG III, [Sar1]ANG II, and [Sar1]ANG III were identical with respect to pressor responses in the alert free-moving rat. In addition, ANG II(3-8) and [Sar1]ANG II(3-8) exhibited 68-70% of the activity of the above compounds, whereas the activity of the shorter COOH-terminal fragments dropped to approximately 13-35%. Pressor responses caused by each of the active forms of angiotensin could be substantially reduced by pretreatment with the specific angiotensin receptor antagonist [Sar1,Thr8]ANG II (Sarthran), suggesting either that these ligands are acting at multiple receptors for ANG II and its fragments, which are all blocked by Sarthran, or that the ligands are acting at a common receptor site. These results, coupled with other recent findings, suggest that the brain angiotensin receptor may be designed to preferentially interact with ANG II and/or ANG III or other angiotensin analogues that structurally resemble ANG III such as [Sar1]ANG II. It is concluded that ANG III's importance as a centrally active ligand has been underestimated and that ANG III may be an active form of angiotensin in the brain.

This article has been cited by other articles:

				J. W. Wright, E. Tamura-Myers, W. L. Wilson, B. P. Roques, C. Llorens-Cortes, R. C. Speth, and J. W. Harding Conversion of brain angiotensin II to angiotensin III is critical for pressor response in rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2003; 284(3): R725 - R733. [Abstract] [Full Text] [PDF]

				J. R. Blair-West, K. D. Carey, D. A. Denton, L. J. Madden, R. S. Weisinger, and R. E. Shade Possible contribution of brain angiotensin III to ingestive behaviors in baboons Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1633 - R1636. [Abstract] [Full Text] [PDF]

				P. D. Potts, A. M. Allen, J. Horiuchi, and R. A. L. Dampney Does angiotensin II have a significant tonic action on cardiovascular neurons in the rostral and caudal VLM? Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2000; 279(4): R1392 - R1402. [Abstract] [Full Text] [PDF]

				T. Tagawa and R. A. L. Dampney AT1 Receptors Mediate Excitatory Inputs to Rostral Ventrolateral Medulla Pressor Neurons From Hypothalamus Hypertension, December 1, 1999; 34(6): 1301 - 1307. [Abstract] [Full Text] [PDF]

				A. Reaux, M. C. Fournie-Zaluski, C. David, S. Zini, B. P. Roques, P. Corvol, and C. Llorens-Cortes Aminopeptidase A inhibitors as potential central antihypertensive agents PNAS, November 9, 1999; 96(23): 13415 - 13420. [Abstract] [Full Text] [PDF]

				R. Ma, H. D. Schultz, and W. Wang Chronic central infusion of ANG II potentiates cardiac sympathetic afferent reflex in dogs Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H15 - H22. [Abstract] [Full Text] [PDF]